NEW YORK–(BUSINESS WIRE) April 01, 2019 –The US Food and Drug Administration (FDA) has approved Fera Pharmaceuticals' New Drug Application (NDA) for Avaclyr (acyclovir ophthalmic ointment) 3% for the treatment of herpetic keratitis….Original Article
You may also like
FDA Approves Miudella (copper intrauterine system) for...
FDA Approves Ctexli (chenodiol) for Cerebrotendinous...
FDA Approves Merilog (insulin-aspart-szjj), a...
FDA Approves Xbryk (denosumab-dssb), a Biosimilar to...
FDA Approves Ospomyv (denosumab-dssb), a Biosimilar to...
FDA Approves Penmenvy (meningococcal groups A, B, C...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.